0
A grad student’s wild idea sparks a major aging breakthrough
A casual conversation between graduate students helped spark a breakthrough in aging research at Mayo Clinic. Researchers discovered that tiny synthetic DNA molecules called aptamers can selectively attach to senescent “zombie cells,” which are linked to aging, cancer, and neurodegenerative disease. The method could eventually help scientists identify and target these cells in living tissue with far greater precision.
The use of CRISPR technology to target specific genes could have profound implications for how we approach aging. While it's exciting, it's also concerning to consider the potential long-term consequences of altering our biology at such a fundamental level. What ethical considerations do we need to be thinking about as this research progresses?